FDA Adverse Event Malfunction Summary report: N

TUFLEX

MDR report key: 11228616 · Received January 26, 2021

Report

Report Number
1000408433-2021-00001
Event Type
Malfunction
Date Received
January 26, 2021
Date of Event
December 29, 2020
Report Date
January 26, 2021
Manufacturer
SOMATEX MEDICAL TECHNOLOGIES GMBH
Product Code
MIJ
UDI-DI
04250195611574
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

THE TUFLEX IS INTENDED AS A PREOPERATIVE MARKER OF NONPALPABLE SUSPECTED BREAST LESIONS TO FACILITATE THE INTRAOPERATIVE LOCALIZATION OF THE FINDINGS BY THE SURGEON. THE TUFLEX CONSISTS OF 19 TWISTED THIN WIRES WHICH GUARANTIES A HIGH FLEXIBILITY. DURING THE REMOVAL OF A SUSPECTED BREAST LESION THE SURGEON TOUCHED THE TUFLEX WIRE WITH THE ELECTRICAL CAUTERY DEVICE SEVERAL TIMES. THIS RESULTED IN A DAMAGE OF THE THIN WIRES AND SOME OF THEM BROKE. THE WHOLE SUSPECTED TISSUE HAS BEEN REMOVED BY THE SURGEON AND DURING THE FOLLOWING EXAMINATION OF THE TISSUE THE BROKEN WIRES HAVE BEEN DETECTED. NO SINGLE WIRE FRAGMENTS HAVE BEEN LEFT IN THE PATIENT. THE ENTIRE WIRE (INCLUDING FRAGMENTS) WERE REMOVED ALONG WITH THE SPECIMEN/LESION. NO ADDITIONAL SURGICAL INTERVENTION WAS NECESSARY. IN THIS CASE THE PATIENT WAS NOT DAMAGED. THE TUFLEX IS A NEW MARKING WIRE WITH A HIGH FLEXIBILITY DUE TO THE 19 TWISTED THIN WIRES. IN THE DEVELOPMENT PHASE OF THE PRODUCT THE POSSIBILITY OF CONTACT BETWEEN THE THIN WIRES AND THE ELECTRICAL CAUTER DEVICE HAS NOT BEEN CONSIDERED. CAUSED BY THE FACT THAT THIS INCIDENT COULD HAPPEN AGAIN WITH THE TUFLEX WIRE, SOMATEX DECIDED TO START A RECALL TO PREVENT PATIENTS FROM ANY HARM.

Description of Event or Problem · 1

DURING THE REMOVAL OF A SUSPECTED BREAST LESION THE MARKING WIRE TUFLEX WAS TAPPED WITH A CAUTERY DEVICE (BOVIE) AND IT SPLINTERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
130208 TUFLEX TUFLEX MIJ SOMATEX MEDICAL TECHNOLOGIES GMBH 271641 51269 04250195611574

Patients

Seq Age Sex Outcome Treatment
1